Guardant Health Inc (NAS:GH)
$ 29.54 0 (0%) Market Cap: 3.61 Bil Enterprise Value: 3.83 Bil PE Ratio: 0 PB Ratio: 52.66 GF Score: 70/100

Guardant Health Inc at Citi Unplugged Medtech and Life Sciences Access Day Transcript

Feb 29, 2024 / 06:00PM GMT
Release Date Price: $19 (+1.44%)
Patrick Donnelly
Citi - Moderator

Being here. I'm Patrick Donnelly, the tools and diagnostics analyst here at Citi. And we have Mike and AmirAli with us from Guardant Health. Talk a little bit screening a little bit on the financial side. But yes, Murali, maybe to start with certainly the news last week that seemed to get the most attention with the oncology piece. So maybe we can start there.

Yes. Maybe tell us what happened. It seemed like it was an FDA decision, ANALYST filling the panel of stock. I'll leave it to you to tell us what happened and where we go from.

Questions & Answers

AmirAli Talasaz
Guardant Health Inc - Co-CEO

Yes, sure. So yes, it's all logistics and scheduling related. So FDA initially told us tentatively they are planning to have this AdCom end of March and very recently, they notified us that they cannot do that now. They are trying to do it late Q2. The reason that they told us is this plan now, which is supposed to have 10 members just have five members at the time that they can be somewhat patient once they need

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot